Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, cyclin E, p27kip1, and Ki-67 in normal placenta and gestational trophoblastic disease

Modern Pathology

Volumn 14, Issue 10, 2001, Pages 1036-1042

  Olvera, Maria ^a   Harris, Selena ^a   Amezcua, Charles A ^a   Mccourty, Althea ^a   Rezk, Sherif ^a   Koo, Charles ^b   Felix, Juan C ^a   Brynes, Russell K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Cdk2; Choriocarcinoma; Cyclin E; E2F 1; Ki 67; p27kip1; Trophoblast

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN E; KI 67 ANTIGEN; PROTEIN P27; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MATURATION; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLASTIC DISEASE;

CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CHORIOCARCINOMA; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; FEMALE; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; TROPHOBLASTIC NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; UTERINE NEOPLASMS;

EID: 0034781160     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880432     Document Type: Article

References (41)

1. Cyclin-dependent kinases and pRb: Regulators of the proliferation-differentiation switch
2. Principles of CDK regulation
3. Cyclin and cyclin-dependent kinases: A biochemical view
4. The role of RB in cell cycle control
5. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein
6. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases
7. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein
8. Role of E2F in cell cycle control and cancer
9. Regulation of cell proliferation by the E2F transcription factors
10. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
11. pRb and E2F-1 in mouse development and tumorigenesis
12. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1
13. Uncoupling of DNA replication and cell cycle progression by human cyclin E
14. Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation
15. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
16. Cell-free degradation of p27(kipl), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome
17. Gestational trophoblastic disease and related lesions
18. Differential diagnosis of hydatidiform moles
19. Problems in the histological assessment of hydatidiform moles: A study on consensus diagnosis and ploidy status by fluorescent in situ hybridization
20. Expression patterns of the cell-cycle inhibitor p27 and the cell-cycle promoter cyclin E in the human placenta throughout gestation: Implications for the control of proliferation
21. Differential expression of G1 cyclins during human placentogenesis
22. Translational inhibition of cyclin BI and appearance of cyclin D1 very early in the differentiation of mouse trophoblast giant cells
23. Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen
24. p53, PCNA, and Ki-67 in hydropic molar and nonmolar placentas: An immunohistochemical study
25. Evaluation of Ki-67 (MIB-1) in placentas with hydropic change and partial and complete hydatidiform mole
26. Proliferative activity in placentas with hydropic change and hydatidiform mole as detected by Ki-67 and proliferating cell nuclear antigen immunostaining
27. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation
28. Expression of the E2F family in human gastrointestinal carcinomas
29. Expression of p27kip1, cyclin E and E2F-1 in primary and metastatic tumors of gastric carcinoma
30. Expression of G1 cyclins and cyclin-dependent kinase-2 activity during terminal differentiation of cultured human trophoblast
31. Reprogramming, the cell cycle for endoreduplication in rodent trophoblast cells
32. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: Implications for the malignant transformation of trophoblasts
33. The role of cyclin E in cell proliferation, development and cancer
34. Cyclin E in human cancers
35. Overexpression of cyclins D1 and E is frequent in Bronchial preneoplasia and precedes squamous cell carcinoma development
36. In vivo cyclin E expression as a marker for early cervical neoplasia
37. Cyclin E gene expression in relapsed adult acute lymphoblastic leukemias of B-cell lineage
38. Expression of cyclin E in human gastric adenomas and adenocarcinomas: Correlation with proliferative activity and p53 status
39. The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis
40. Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation
41. Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications